Immunovant (IMVT) Payables (2018 - 2026)
Immunovant's Payables was $10.14 million in fiscal Q1 2027 (quarter ended Jun 30, 2026), up 29.3% from $7.84 million a year earlier and up 34.4% from the prior quarter.
Powered by 
Analysis
Immunovant (IMVT) Payables (2018 - 2026) Analysis & Trends
At the end of FY2026 (ended Mar 31, 2026), Payables at Immunovant came in at $7.54 million, down 57.3% from FY2025.
- Payables shows a five-year compound annual growth rate of 25.4% (FY2021 to FY2026).
- In earlier fiscal years, Payables was $17.66 million in FY2025 (+146.8%), $7.16 million in FY2024 (+428.8%), $1.35 million in FY2023 (-92.7%) and $18.63 million in FY2022 (+666.0%).
- The fiscal Q1 2027 figure marks the highest quarterly Payables since fiscal Q4 2025.
- Compared with a year earlier, Payables was higher in four of the last eight quarters, with growth averaging 68.7%.
- The best year-over-year quarter for Payables over five years was fiscal Q4 2022 (growth of 666.0%); the worst was fiscal Q4 2023 (a decline of 92.7%).
- Per Business Quant data, IMVT's Payables in the three fiscal quarters before Q1 2027 was $7.54 million (Q4 2026), $8.62 million (Q3 2026) and $6.92 million (Q2 2026).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Payables (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,264.65 Bn | 1,238.27 Bn | 20.46 Bn | 5.79 Bn |
| 2 | Johnson & Johnson | 677.74 Bn | 597.60 Bn | 17.30 Bn | 18.17 Bn |
| 3 | AbbVie | 517.10 Bn | 485.11 Bn | 13.12 Bn | 34.43 Bn |
| 4 | Merck | 362.23 Bn | 325.17 Bn | 13.19 Bn | 7.17 Bn |
| 5 | Novartis Ag | 315.90 Bn | 276.16 Bn | 11.24 Bn | 4.26 Bn |
| 6 | Astrazeneca | 289.40 Bn | 266.24 Bn | 12.86 Bn | 22.89 Bn |
| 7 | Amgen | 249.90 Bn | 201.56 Bn | 7.58 Bn | 2.95 Bn |
| 8 | Gilead Sciences | 209.15 Bn | 184.26 Bn | 6.73 Bn | 934.00 Mn |
| 9 | Pfizer | 165.88 Bn | 113.23 Bn | 12.56 Bn | 4.07 Bn |
| 10 | Immunovant | 7.32 Bn | 4.11 Bn | - | 10.14 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 10.14 Mn |
| Mar 31, 2026 | 7.54 Mn |
| Dec 31, 2025 | 8.62 Mn |
| Sep 30, 2025 | 6.92 Mn |
| Jun 30, 2025 | 7.84 Mn |
| Mar 31, 2025 | 17.66 Mn |
| Dec 31, 2024 | 19.82 Mn |
| Sep 30, 2024 | 20.73 Mn |
| Jun 30, 2024 | 11.04 Mn |
| Mar 31, 2024 | 7.16 Mn |
| Dec 31, 2023 | 3.91 Mn |
| Sep 30, 2023 | 7.51 Mn |
| Jun 30, 2023 | 26.46 Mn |
| Mar 31, 2023 | 1.35 Mn |
| Dec 31, 2022 | 14.00 Mn |
| Sep 30, 2022 | 7.46 Mn |
| Jun 30, 2022 | 1.07 Mn |
| Mar 31, 2022 | 18.63 Mn |
| Dec 31, 2021 | 3.83 Mn |
| Sep 30, 2021 | 4.24 Mn |
API Access
Immunovant Payables API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=payables&ticker=IMVT&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "payables", "ticker": "IMVT", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=payables&ticker=IMVT&period=max&api_key=YOUR_API_KEY");
const data = await res.json();